展开

镥锭

产品编号 L110934 | CAS号 7439-94-3 | Aladdin
Lutetium
99.9% metals basis
组合的产品项目
货号 规格 库存 价格 数量
L110934-1g 99.9% metals basis 上海(>10)
北方(预计3-5个工作日)
 
L110934-5g 99.9% metals basis 上海(1)
北方(预计3-5个工作日)
 
客户看了后又看了下面的产品

属性

敏感性 对湿度敏感
密度 9.8400
熔点 1663°C
沸点 3395°C
存贮条件 充氩保存

描述

产品介绍 质软,有延展性。在空气中比较稳定,能缓慢地跟水反应,能溶于稀酸。氧化镥呈白色,镥盐无色。
别名 镥粉 ;金属镥;
应用 用于电子工业和科学研究等。
编写您自己的评论
只有注册的用户才可以写评论。请 登录 创建帐户
标识符号 GHS02 GHS02
信号词 Danger
警示性声明 P210
危害声明 H228
个人防护设备 Eyeshields,Gloves,type N95 (US),type P1 (EN143) respirator filter
WGK德国 3
参考文献
Yu Y Gao, Bin B Feng, Qinghong Q Fang, Jian J Gong
The LuVO4:Ln3+ (Ln3+ = Eu, Dy, and Sm) nano/microcrystals with different shapes were synthesized through a simple hydrothermal route assisted by trisodium citrate (Na3Cit). X-ray diffraction (XRD), X-...Read More
Fiona C Coomer, Edmund J Cussen
We report here the synthesis of the site ordered double perovskite Ba(2)LuMoO(6). Rietveld refinement of room temperature powder x-ray diffraction measurements indicates that it crystallizes in the cu...Read More
Fares Al-Ejeh, Wei Shi, Mariska Miranda, Peter T Simpson, Ana Cristina Vargas, Sarah Song, Adrian P Wiegmans, Alex Swarbrick, Alana L Welm, Michael P Brown, Georgia Chenevix-Trench, Sunil R Lakhani, Kum Kum Khanna
Triple-negative breast cancer (TNBC) is associated with poor survival. Chemotherapy is the only standard treatment for TNBC. The prevalence of BRCA1 inactivation in TNBC has rationalized clinical tria...Read More
Anna Orlova, Andreas Jonsson, Daniel Rosik, Hans Lundqvist, Malin Lindborg, Lars Abrahmsen, Caroline Ekblad, Fredrik Y Frejd, Vladimir Tolmachev
Because of their better penetration, smaller targeting proteins may be superior to antibodies for radioimmunotherapy of solid tumors. Therefore, Affibody molecules (6.5 kDa) have a potential for being...Read More
Esra Hatipoglu, Hasan Kepicoglu, Elif Rusen, Levent Kabasakal, Sadi Gundogdu, Pinar Kadioglu
We present a 39-year-old woman who was previously diagnosed with Von Hippel Lindau Disease (VHLD). She had surgery and radiotherapy for cranial hemangioblastoma (HA) 11 years ago and had unilateral ad...Read More
Rebecca A Dumont, MariaLuisa Tamma, Friederike Braun, Sandra Borkowski, Jean Claude Reubi, Helmut Maecke, Wolfgang A Weber, Rosalba Mansi
The gastrin-releasing peptide receptor (GRPr) is overexpressed in prostate cancer and is an attractive target for radionuclide therapy. In addition, inhibition of the protein kinase mammalian target o...Read More
J L Parus, R Mikolajczak
The paper focuses on the β-emitting radionuclides which might be useful for peptide receptor radionuclide therapy, PRRT. For the effective design of the radiopharmaceutical, the choice of radionuclid...Read More
Jostein Dahle, Ada H V Repetto-Llamazares, Camilla S Mollatt, Katrine B Melhus, Oyvind S Bruland, Arne Kolstad, Roy H Larsen
The monoclonal antibody against CD20, rituximab, alone, or as part of combination therapies, is standard therapy for non-Hodgkin's B-cell lymphoma. Despite significantly better clinical results o...Read More
Arnaud A Dieudonné, Robert F RF Hobbs, Rachida R Lebtahi, Fabien F Maurel, Sébastien S Baechler, Richard L RL Wahl, Ariane A Boubaker, Dominique D Le Guludec, Georges G Sgouros, Isabelle I Gardin
Dose kernel convolution (DK) methods have been proposed to speed up absorbed dose calculations in molecular radionuclide therapy. Our aim was to evaluate the impact of tissue density heterogeneities (...Read More
R Boada, M A Laguna-Marco, C Piquer, J Chaboy
The magnetic polarization of the Lu 5d states through the Ho(1-x)Lu(x)(Fe(1-y)Al(y))(2) series has been studied by means of x-ray magnetic circular dichroism. A combined study of the dichroic signals ...Read More
Cristina Müller, Harriet Struthers, Christian Winiger, Konstantin Zhernosekov, Roger Schibli
The folate receptor (FR) has proven a valuable target for nuclear imaging using folic acid radioconjugates. However, using folate-based radiopharmaceuticals for therapy has long been regarded as an un...Read More
Yang Yang, Yun Sun, Tianye Cao, Juanjuan Peng, Ying Liu, Yongquan Wu, Wei Feng, Yingjian Zhang, Fuyou Li
Upconversion luminescence (UCL) properties and radioactivity have been integrated into NaLuF(4):(153)Sm,Yb,Tm nanoparticles by a facile one-step hydrothermal method, making these nanoparticles potenti...Read More
A I Martin, N Horgan
We're sorry this abstract is currently not available....Read More
Ksenija R KR Kumri?, Goran T GT Vladisavljevi?, Jelena S JS ?or?evi?, Jan ?ke J? J?nsson, Tatjana M TM Trti?-Petrovi?
In this study, the mass transport resistance in liquid-phase microextraction (LPME) in a single hollow fiber was investigated. A mathematical model has been developed for the determination of the over...Read More
J Wu, Y L Liu, S J Chang, M M Chao, S Y Tsai, D E Huang
Monte Carlo (MC) simulation has been commonly used in the dose evaluation of radiation accidents and for medical purposes. The accuracy of simulated results is affected by the particle-tracking algori...Read More
Harshad R Kulkarni, Vikas Prasad, Christiane Schuchardt, Richard P Baum
The spleen receives a high mean absorbed radiation dose during peptide receptor radionuclide therapy (PRRNT). The aim of this study is to correlate the radiation dose to spleen with the effect on bloo...Read More
Harshad R Kulkarni, Christiane Schuchardt, Richard P Baum
The aim of this study is to correlate the uptake, residence time, and resulting mean absorbed dose in the kidneys with the posttherapy effect on renal function using the two most commonly used somatos...Read More
F Forrer, C Oechslin-Oberholzer, B Campana, H Maecke, J Mueller-Brand, A Lohri
Aim: The aim of the study was to explore the clinical response to 177Lutetium-DOTA-rituximab (177Lu-D-R) and to determine the maximum tolerated dose (MTD) in the treatment of patients with relapsed fo...Read More
Erik de Blois, Ho Sze Chan, Mark Konijnenberg, Rory de Zanger, Wouter A P Breeman
An overview how to measure and to quantify radiolysis by the addition of quenchers and to maintain Radio-Chemical Purity (RCP) of vulnerable methionine-containing regulatory peptides is presented. Hig...Read More
Peixiong Zhang, Yin Hang, LianHan Zhang
The use of Pr3+ codoping for enhancement of the Ho3+:5I6 →5I7 mid-IR emissions were investigated in the LiLuF4 crystal for the first time. It was found that Pr3+ greatly increased Ho3+ 2.9 μm emiss...Read More
S Shcherbinin, H Piwowarska-Bilska, A Celler, B Birkenfeld
We investigated the quantitative accuracy of SPECT/CT imaging studies as would be performed before and after targeted radionuclide therapy (TRT) using phantom experiments with (i) (99m)Tc, (ii) 1??Lu ...Read More
M Trevisani, K V Ivanovskikh, F Piccinelli, A Speghini, M Bettinelli
Ca(9)Lu(PO(4))(7):Ce (3+) and Ca (9)Lu (PO (4))(7):Pr (3+) polycrystalline materials were synthesized by solid state reaction at high temperature. The materials were characterized by powder x-ray diff...Read More
Xuejuan Wang, Melpomeni Fani, Stefan Schulz, Jean Rivier, Jean Claude Reubi, Helmut R Maecke
Targeting of tumours positive for somatostatin receptors (sst) with radiolabelled peptides is of interest for tumour localization, staging, therapy follow-up and targeted radionuclide therapy. The pep...Read More
Kalevi Kairemo, Aki Kangasm?ki
Molecular radiotherapy combines the potential of a specific tracer (vector) targeting tumor cells with local radiotoxicity. Designing a specific tumor-targeting/killing combination is a tailoring proc...Read More
Jurgen Seidel, Wenze Xi, John W Kakareka, Thomas J Pohida, Elaine M Jagoda, Michael V Green, Peter L Choyke
We describe a prototype positron projection imager (PPI) for visualizing the whole-body biodistribution of positron-emitting compounds in mouse-size animals. The final version of the PPI will be integ...Read More
S M van den Bosch, R Rossin, P Renart Verkerk, W Ten Hoeve, H M Janssen, J Lub, M S Robillard
We report on our evaluation of the strain-promoted cyclooctyne-azide cycloaddition reaction for use in tumor pretargeting, comprising a side-by-side comparison of probes 1-3 bearing three distinct cyc...Read More
So-Young Lee, Young Don Hong, Hak-Sung Kim, Sun-Ju Choi
For the development of safe and effective protein-based radiolabeled complexes such as radioimmunotherapy (RIT), the selection of the radionuclides and the chelating agents used for the radiolabeling ...Read More
Ada H V Repetto-Llamazares, Roy H Larsen, Camilla Mollatt, Michael Lassmann, Jostein Dahle
The biodistribution of the anti-CD37 radioimmunoconjugate 177Lu-tetraxetan-tetulomab (177Lu-DOTA-HH1) was evaluated. Biodistribution of 177Lu-tetraxetan-tetulomab was compared with 177Lu-tetraxetan-ri...Read More

质检报告(COA)

请输入批号: